2BB score and signals
Vir Biotechnology, Inc.’s current 2BB score is 48 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 70 | High |
| Momentum | 55 | Stable |
| Financial strength | 30 | Weak |
| Quality | 98 | Very Strong |
| Risk | 35 | Low |
Company facts
| CEO | Marianne De Backer |
| Headquarters | San Francisco, California, United States |
| Founded | Apr 7, 2016 |
| Employees | 367 |
| 52-week range | $4.82 – $11.96 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2027-02-22 | — | -0.6727 | — | $6.81M |
| 2026-10-29 | — | -0.7514 | — | $105,242.00 |
| 2026-08-05 | — | 0.3363 | — | $218.62M |
| 2026-05-06 | -0.85 | -0.0964 | $29,000.00 | $110.38M |
Related companies
